Renal Nerve Denervation-A Hypertension Bubble?

Journal of Clinical Hypertension

Volumn 16, Issue 7, 2014, Pages 472-474

  Myers, Martin G ^a,b   Wijeysundera, Harindra C ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITOR; BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; DRUG MONITORING; EDITORIAL; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY DENERVATION; MEAN ARTERIAL PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; STUDY DESIGN; DENERVATION; FEMALE; MALE; RENAL ARTERY;

DENERVATION; FEMALE; HUMANS; HYPERTENSION; MALE; RENAL ARTERY;

EID: 84904112401     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12334     Document Type: Editorial

References (11)

1. Garber PM. Tulipmania. J Polit Econ. 1989;97:535-560.
2. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multi-centre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
3. Symplicity-HTN 2 Investigators. Renal sympathetic nerve denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
4. National Institute for Health and Clinical Excellence. Hypertension NICE Clinical Guidelines 127. National Clinical Guidelines Centre: London, UK; August 2011.
5. Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-1401.
6. Sedgwick P. The Hawthorne effect. BMJ. 2011;344:d8262.
7. Myers MG. Pseudoresistant hypertension attributed to white-coat effect. Hypertension. 2012;59:532-533.
8. Persu A, Jin Y, Baelen M, et al. Eligibility for renal denervation experience from 11 European centers. Hypertension. 2014 Mar 24. [Epub ahead of print].
9. Ceral J, Habrdova V, Vorisek V, et al. Difficult to control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsive from non-adherence to recommended therapy. Hypertens Res. 2011;34:87-90.
10. Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31:766-774.
11. Brinker S, Pandey A, Ayers C, et al. Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension. JACC. 2014;63:834-835.